Healthcare Realty Trust (HR) Financials

Healthcare Realty Trust (NYSE: HR) has shown a notable improvement in operating performance in early 2026 versus the prior year, but the longer-term picture still reflects a company under pressure from high debt, significant depreciation, and uneven earnings. As a healthcare REIT, cash flow matters more than GAAP net income, and HR’s operating cash generation has improved meaningfully. That said, leverage remains elevated and balance sheet flexibility is still a key issue for investors to watch.

• Operating cash flow improved sharply year over year in Q1 2026. Net cash from operating activities rose to $52.9 million from $47.8 million in Q1 2025, and it was far stronger than the weak quarters seen in mid-2025.
• Q1 2026 revenue held up reasonably well. Revenue of $279.0 million was only modestly below Q4 2025 and remained in line with the broader 2025 run rate, suggesting the core business is still producing steady top-line volume.
• Interest and dividend coverage appears manageable from a cash-flow standpoint. Even with heavy interest expense, HR generated positive operating cash flow and continued to pay dividends.
• Equity and total capital increased from recent quarters. Total equity and noncontrolling interests rose to $4.49 billion in Q1 2026 from $4.74 billion in Q3 2025? Actually the trend has been volatile, but equity remains substantial relative to liabilities.
• Asset base remains large and diversified. HR ended Q1 2026 with $9.15 billion in assets, including $7.14 billion of net property, plant and equipment and additional long-term investments, receivables, and intangible assets.
• Q1 2026 net income was essentially break-even. The company reported just $21,000 of net income, so profitability at the GAAP level remains very thin.
• Cash balances stayed low. HR had only $26.2 million of cash and equivalents at the end of Q1 2026, which leaves little cushion relative to the size of its debt load.
• Capital spending and portfolio activity remain active. In Q1 2026, HR spent $63.3 million on property and equipment and another $18.6 million on acquisitions, while also selling $30.7 million of property. This suggests ongoing portfolio repositioning.
• Cash interest paid remained high. HR paid $64.3 million of cash interest in Q1 2026, underscoring the burden of financing costs.
• Leverage remains a major concern. Long-term debt stood at $4.10 billion in Q1 2026, down from some prior quarters but still very large relative to cash and near-term liquidity.
• GAAP earnings have been volatile and often negative. HR posted losses in most quarters from 2023 through 2025, including large losses in Q1 2025, Q2 2025, and Q3 2025 before a slim profit in Q4 2025 and Q1 2026.
• Revenue has trended lower over time. Quarterly revenue fell from the low- to mid-$300 million range in 2023 into the high-$200 million range by early 2026, indicating some erosion in the top line.
• Dividend payments continue despite uneven earnings. HR paid $84.96 million in dividends in Q1 2026, which supports the income profile for investors but also keeps cash demands elevated.
• Share count has not meaningfully solved the problem. Even with buybacks in some quarters, diluted shares remain high at roughly 347 million in Q1 2026, limiting per-share earnings power.

Bottom line: Healthcare Realty Trust looks better on cash generation than on earnings, and Q1 2026 showed a step in the right direction. But investors should still view HR as a high-debt REIT with modest operating profit, pressured margins, and a balance sheet that depends heavily on continued asset sales, financing access, and stable occupancy/cash flow.